2016骨质疏松症重要研究一览

2016-08-10 MedSci MedSci原创

骨质疏松症(osteoporosis,OP)是一种以骨强度下降、骨折风险增加为特征的骨骼系统疾病,骨质疏松症(osteoporosis)是由于多种原因导致的骨密度和骨质量下降,骨微结构破坏,造成骨脆性增加,从而容易发生骨折的全身性骨病。骨质疏松症分为原发性和继发性二大类。原发性骨质疏松症又分为绝经后骨质疏松症(Ⅰ型)、老年性骨质疏松症(Ⅱ型)和特发性骨质疏松(包括青少年型)三种。早在1993年

骨质疏松症(osteoporosis,OP)是一种以骨强度下降、骨折风险增加为特征的骨骼系统疾病,由于多种原因导致的骨密度和骨质量下降,骨微结构破坏,造成骨脆性增加,从而容易发生骨折的全身性骨病。骨质疏松症分为原发性和继发性二大类。原发性骨质疏松症又分为绝经后骨质疏松症(Ⅰ型)、老年性骨质疏松症(Ⅱ型)和特发性骨质疏松(包括青少年型)三种。

早在1993年《美国风湿病学会对关节炎和风湿性疾病的命名和分类》已将OP包括其中,但由于我国风湿病专业起步较晚,风湿病学者对其认识和研究存在诸多不足,发表有关OP的研究文章的数量少于内分泌和骨科等专业,风湿免疫科临床医生对OP诊治也缺乏足够的重视,漏诊漏治的情况并不鲜见。

近期有骨质疏松症研究领域的大量基础和临床研究,从不同方向、不同角度对骨质疏松症及其并发症的临床诊治进行了深入研究,为骨质疏松症的临床管理寻找最新方向。本文就近期骨质疏松症领域重要研究进行回顾。

【1】Bone:特立帕肽治疗骨质疏松症+2型糖尿病患者

根据对DANCE试验的事后分析,成人2型糖尿病和骨质疏松症患者进行指定的Forteo治疗,可以降低椎骨骨折发生率,增加骨密度和减少背部疼痛。

加利福尼亚大学的Ann V. Schwartz博士和同事分析了4042名骨折高风险的骨质疏松症成年人,其中291例患者有2型糖尿病(平均年龄为69岁)。分析包括了每天至少使用一个剂量的特立帕肽(20 µg/天,皮下注射);影像学诊断由调查人员自行裁决;使用DXA评估参与者的BMD。

“特立帕肽抗骨吸收药物治疗可能有助于保持和进一步提高患者的骨密度,以及较低的非脊椎骨折的发病率,糖尿病和骨质疏松症患者在完成一个疗程的特立帕肽治疗后,应考虑后续骨质疏松治,”研究人员写道。“这些研究结果表明,2型糖尿病患者的骨骼管理还需要更大的临床关注。”(文章详见--Bone:特立帕肽治疗骨质疏松症+2型糖尿病患者

【2】Bone:绝经后女性使用抗抑郁药会增加骨质疏松症风险

骨质疏松症和抑郁症是全球主要的健康问题,那么治疗抑郁症的抗抑郁药和骨骼健康之间有什么关联呢?就此研究者进行了一项研究,探究随时间推移,绝经后妇女使用抗抑郁药物和骨质流失间的关系。

该研究从OSTPRE试验队列中共纳入了1988名57-67岁女性,分别在1999年和2004年检测参与者的股骨颈骨密度(BMD)。

研究结果表明,SSRIs以剂量依赖的方式加快绝经后女性骨质流失,使用TCA和其他抗抑郁药也会导致骨质流失。所以对绝经后女性开具抗抑郁药的处方时应考虑到其可能增加骨质疏松症的风险。(文章详见--Bone:绝经后女性使用抗抑郁药会增加骨质疏松症风险

【3】墨西哥龙舌兰(植物)提取物,有助于治疗骨质疏松症

墨西哥龙舌兰是一种非常传统的用于制作饮料的植物原料,一项新的研究发现,蓝色龙舌兰提取物能够提高机体对钙、镁的吸收量,通过促进必要矿物质的吸收来维持骨骼健康。并且龙舌兰提取物的作用效果已经得到了研究证实。

该项目的领导人 Mercedes López 博士表示:“对骨质疏松症患者来说,龙舌兰中富含果聚糖,在肠道微生物的作用下,龙舌兰提取物能够促进新骨形成。”

该研究结论为骨质疏松症的治疗工作提供了无限可能,据国际骨质疏松基金会统计,在全球范围内,骨质疏松已经对2亿人造成了困扰,这也就意味着,4,000万人面临骨折风险。(文章详见--墨西哥龙舌兰(植物)提取物,有助于治疗骨质疏松症)(文章详见--墨西哥龙舌兰(植物)提取物,有助于治疗骨质疏松症

【4】JCEM:绝经后骨质疏松症,双药联合优于单药(DATA-HRpQCT研究)

近期发表在J Clin Endocrinol Metab的研究表明,治疗绝经后骨质疏松症时,联合使用狄诺塞麦和特立帕肽将优于单药治疗,主要表现在臀部和脊柱骨矿物质密度的增加。

研究者对94名绝经后骨质疏松症女性进行了一项随机对照试验,探究联合治疗2年对患者骨骼微结构和骨强度的影响。研究者将患者随机分为每日皮下注射特立帕肽20μg组、每6个月皮下注射狄诺塞麦60μg组、两种药物联合治疗组,3组治疗时间均为2年。

研究结果表明,使用狄诺塞麦和特立帕肽联合治疗两年,可显著改善骨微结构和骨强度,疗效优于单药治疗,尤其是骨密度。(文章详见--JCEM:绝经后骨质疏松症,双药联合优于单药(DATA-HRpQCT研究))

【5】维生素K 与骨质疏松症也密切相关

韩国诸(JeSH)等研究显示联合应用维生素K2、维生素D和钙可减少未羧化骨钙素的血药浓度,同时可增加60岁以上绝经后妇女的骨密度。平尾(HiraoM)等研究显示维生素K2和阿仑膦酸钠合用可增加绝经后骨质疏松症女性的骨钙素羧化和骨密度。

布拉姆(Braam)对155名绝经后女性随访3年的研究发现,补充维生素K2组髋部骨密度下降幅度较安慰剂组低1.7%,较补充钙、镁、锌和维生素D组低1.3%,且维生素K2与维生素D在增加骨密度上具有协同作用。以上研究表明维生素K2可与维生素D、钙等合用,用于改善骨密度,治疗骨质疏松症。

另外也有研究显示,维生素K缺乏可增加年龄相关性骨丢失及骨质疏松性骨折的患病风险。

骨质疏松症患者每日补充维生素K2后2年,腰椎骨密度显著高于未治疗的对照组,椎体骨折发生率降低达64%,其他观察部位(前臂、股骨颈及其他)的骨折发生率降低56%。张(CheungAM)等对440名绝经后骨质疏松症患者进行的一项为期2年的随机对照研究显示,补充维生素K后2~4年,不能防止与年龄相关的骨密度下降,但可能减少绝经后女性骨质疏松性骨折及癌症的发病率。(文章详见--维生素K 与骨质疏松症也密切相关

【6】Bone:双膦酸盐类药物治疗骨质疏松症(荟萃分析)

发表在Bone杂志上的一项研究表明,双膦酸盐类药物可有效治疗骨质疏松症。

研究共纳入了46项随机对照试验(RCT),27篇RCTs提供骨折数据,35篇RCTs提供了BMD数据进行分析。相比安慰剂,唑来膦酸与椎体骨折的最大治疗效果相关(HR 0.41, 95% CrI: 0.28, 0.56),与BMD变化的百分比有关(3.21, 95%: CrI 2.52, 3.86)。利塞膦酸与非脊椎和手腕骨折的最大治疗效果相关(HR 0.72, 95%: CrI 0.53, 0.89;HR 0.77, 95%: CrI 0.44, 1.24)。阿仑膦酸钠与髋部骨折的最大治疗效果有关(HR 0.78, 95% CrI: 0.44, 1.30)。

与安慰剂相比,所有的治疗方法对骨折和股骨颈骨密度都有益处。所有治疗在椎体骨折和股骨颈骨密度的百分比变化的治疗效果上具有统计学意义。两两治疗组比较表明,在骨折方面,没有统计学意义。目前还没有证据表明,不同的治疗效果与性别和年龄有关。(文章详情--Bone:双膦酸盐类药物治疗骨质疏松症(荟萃分析)

【7】Nat Commun:研究发现罕见骨质疏松症

来自苏黎世大学和苏黎世大学儿童医院的研究人员发现了第一个遗传性X染色体类型的先天性成骨发育不全症,也称为骨质疏松症。在瑞士约有300到400人,全球大约有五十万人患有骨质疏松症,该病会导致他们的骨头像玻璃一样脆弱。他们的骨形成不仅不好,而且身体组织中其它部位含有的结缔组织也受到了影响。

这些激活的蛋白能与DNA结合,并能调节基因参与到骨生长和固醇代谢中,而且能调节细胞的压力,这在斑马鱼中表现的比较明显。不久之后研究人员发现,IFAP综合症是一组人类罕见的皮肤疾病,它是由MBTPS2突变引起的。

“令人惊讶的是,突变基因MBTPS2也能引发一种完全不同的疾病,即成骨不全症。”Marianne Rohrbach说道。同一基因中的突变怎样以及为什么可以引发两个完全不同的疾病目前还尚不清楚。Cecilia Giunta 和 Marianne Rohrbach说现在他们的研究方向是查找发病机制。科学家们希望能够有新的治疗方法治疗这种疾病。(文章详见--Nat Commun:研究发现罕见骨质疏松症

本文系梅斯医学(MedSci)原创编译整理,欢迎转载!更多资讯,请下载"辣眼睛的医学科研神器之梅斯医学APP”!扫一下二维码即可: 


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=105150, encodeId=5a8a1051503c, content=谢谢!学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYa2dQhybFWiaOltUMXgzZLaoNhJDib46KINHiaFYjvYrawnjiaPdibLyGwJtjd0rId9ffwzEdNVtjngg/132, createdBy=e0a41314680, createdName=shaojinkang, createdTime=Fri Aug 26 22:40:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592336, encodeId=5a891592336ab, content=<a href='/topic/show?id=6dc2101853ed' target=_blank style='color:#2F92EE;'>#骨质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101853, encryptionId=6dc2101853ed, topicName=骨质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d018108513, createdName=Eleven17, createdTime=Fri Aug 12 03:20:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97567, encodeId=715b9e567de, content=好文章,值得阅读,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Aug 11 19:31:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97568, encodeId=4a889e56825, content=好文章,值得阅读,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Aug 11 19:31:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97313, encodeId=86ef9e313fe, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 10 16:56:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97290, encodeId=269e9e29052, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Wed Aug 10 15:56:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97265, encodeId=732f9e265d7, content=讲的非常广!, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLF3V7KY7WyRVHCticgpdCWVsqAsLGF1UrrVc5TFS9ZI2DrEs5plCGBUaLqHXvCU4fhImjFdZ9PjiaS/0, createdBy=8f971728670, createdName=1dee1b88m43(暂无匿称), createdTime=Wed Aug 10 13:47:00 CST 2016, time=2016-08-10, status=1, ipAttribution=)]
    2016-08-26 shaojinkang

    谢谢!学习了!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=105150, encodeId=5a8a1051503c, content=谢谢!学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYa2dQhybFWiaOltUMXgzZLaoNhJDib46KINHiaFYjvYrawnjiaPdibLyGwJtjd0rId9ffwzEdNVtjngg/132, createdBy=e0a41314680, createdName=shaojinkang, createdTime=Fri Aug 26 22:40:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592336, encodeId=5a891592336ab, content=<a href='/topic/show?id=6dc2101853ed' target=_blank style='color:#2F92EE;'>#骨质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101853, encryptionId=6dc2101853ed, topicName=骨质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d018108513, createdName=Eleven17, createdTime=Fri Aug 12 03:20:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97567, encodeId=715b9e567de, content=好文章,值得阅读,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Aug 11 19:31:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97568, encodeId=4a889e56825, content=好文章,值得阅读,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Aug 11 19:31:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97313, encodeId=86ef9e313fe, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 10 16:56:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97290, encodeId=269e9e29052, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Wed Aug 10 15:56:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97265, encodeId=732f9e265d7, content=讲的非常广!, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLF3V7KY7WyRVHCticgpdCWVsqAsLGF1UrrVc5TFS9ZI2DrEs5plCGBUaLqHXvCU4fhImjFdZ9PjiaS/0, createdBy=8f971728670, createdName=1dee1b88m43(暂无匿称), createdTime=Wed Aug 10 13:47:00 CST 2016, time=2016-08-10, status=1, ipAttribution=)]
    2016-08-12 Eleven17
  3. [GetPortalCommentsPageByObjectIdResponse(id=105150, encodeId=5a8a1051503c, content=谢谢!学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYa2dQhybFWiaOltUMXgzZLaoNhJDib46KINHiaFYjvYrawnjiaPdibLyGwJtjd0rId9ffwzEdNVtjngg/132, createdBy=e0a41314680, createdName=shaojinkang, createdTime=Fri Aug 26 22:40:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592336, encodeId=5a891592336ab, content=<a href='/topic/show?id=6dc2101853ed' target=_blank style='color:#2F92EE;'>#骨质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101853, encryptionId=6dc2101853ed, topicName=骨质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d018108513, createdName=Eleven17, createdTime=Fri Aug 12 03:20:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97567, encodeId=715b9e567de, content=好文章,值得阅读,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Aug 11 19:31:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97568, encodeId=4a889e56825, content=好文章,值得阅读,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Aug 11 19:31:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97313, encodeId=86ef9e313fe, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 10 16:56:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97290, encodeId=269e9e29052, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Wed Aug 10 15:56:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97265, encodeId=732f9e265d7, content=讲的非常广!, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLF3V7KY7WyRVHCticgpdCWVsqAsLGF1UrrVc5TFS9ZI2DrEs5plCGBUaLqHXvCU4fhImjFdZ9PjiaS/0, createdBy=8f971728670, createdName=1dee1b88m43(暂无匿称), createdTime=Wed Aug 10 13:47:00 CST 2016, time=2016-08-10, status=1, ipAttribution=)]
    2016-08-11 jaysppr

    好文章,值得阅读,谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=105150, encodeId=5a8a1051503c, content=谢谢!学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYa2dQhybFWiaOltUMXgzZLaoNhJDib46KINHiaFYjvYrawnjiaPdibLyGwJtjd0rId9ffwzEdNVtjngg/132, createdBy=e0a41314680, createdName=shaojinkang, createdTime=Fri Aug 26 22:40:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592336, encodeId=5a891592336ab, content=<a href='/topic/show?id=6dc2101853ed' target=_blank style='color:#2F92EE;'>#骨质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101853, encryptionId=6dc2101853ed, topicName=骨质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d018108513, createdName=Eleven17, createdTime=Fri Aug 12 03:20:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97567, encodeId=715b9e567de, content=好文章,值得阅读,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Aug 11 19:31:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97568, encodeId=4a889e56825, content=好文章,值得阅读,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Aug 11 19:31:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97313, encodeId=86ef9e313fe, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 10 16:56:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97290, encodeId=269e9e29052, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Wed Aug 10 15:56:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97265, encodeId=732f9e265d7, content=讲的非常广!, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLF3V7KY7WyRVHCticgpdCWVsqAsLGF1UrrVc5TFS9ZI2DrEs5plCGBUaLqHXvCU4fhImjFdZ9PjiaS/0, createdBy=8f971728670, createdName=1dee1b88m43(暂无匿称), createdTime=Wed Aug 10 13:47:00 CST 2016, time=2016-08-10, status=1, ipAttribution=)]
    2016-08-11 jaysppr

    好文章,值得阅读,谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=105150, encodeId=5a8a1051503c, content=谢谢!学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYa2dQhybFWiaOltUMXgzZLaoNhJDib46KINHiaFYjvYrawnjiaPdibLyGwJtjd0rId9ffwzEdNVtjngg/132, createdBy=e0a41314680, createdName=shaojinkang, createdTime=Fri Aug 26 22:40:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592336, encodeId=5a891592336ab, content=<a href='/topic/show?id=6dc2101853ed' target=_blank style='color:#2F92EE;'>#骨质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101853, encryptionId=6dc2101853ed, topicName=骨质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d018108513, createdName=Eleven17, createdTime=Fri Aug 12 03:20:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97567, encodeId=715b9e567de, content=好文章,值得阅读,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Aug 11 19:31:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97568, encodeId=4a889e56825, content=好文章,值得阅读,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Aug 11 19:31:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97313, encodeId=86ef9e313fe, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 10 16:56:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97290, encodeId=269e9e29052, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Wed Aug 10 15:56:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97265, encodeId=732f9e265d7, content=讲的非常广!, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLF3V7KY7WyRVHCticgpdCWVsqAsLGF1UrrVc5TFS9ZI2DrEs5plCGBUaLqHXvCU4fhImjFdZ9PjiaS/0, createdBy=8f971728670, createdName=1dee1b88m43(暂无匿称), createdTime=Wed Aug 10 13:47:00 CST 2016, time=2016-08-10, status=1, ipAttribution=)]
    2016-08-10 1dd8c52fm63(暂无匿称)

    学习学习!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=105150, encodeId=5a8a1051503c, content=谢谢!学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYa2dQhybFWiaOltUMXgzZLaoNhJDib46KINHiaFYjvYrawnjiaPdibLyGwJtjd0rId9ffwzEdNVtjngg/132, createdBy=e0a41314680, createdName=shaojinkang, createdTime=Fri Aug 26 22:40:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592336, encodeId=5a891592336ab, content=<a href='/topic/show?id=6dc2101853ed' target=_blank style='color:#2F92EE;'>#骨质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101853, encryptionId=6dc2101853ed, topicName=骨质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d018108513, createdName=Eleven17, createdTime=Fri Aug 12 03:20:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97567, encodeId=715b9e567de, content=好文章,值得阅读,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Aug 11 19:31:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97568, encodeId=4a889e56825, content=好文章,值得阅读,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Aug 11 19:31:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97313, encodeId=86ef9e313fe, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 10 16:56:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97290, encodeId=269e9e29052, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Wed Aug 10 15:56:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97265, encodeId=732f9e265d7, content=讲的非常广!, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLF3V7KY7WyRVHCticgpdCWVsqAsLGF1UrrVc5TFS9ZI2DrEs5plCGBUaLqHXvCU4fhImjFdZ9PjiaS/0, createdBy=8f971728670, createdName=1dee1b88m43(暂无匿称), createdTime=Wed Aug 10 13:47:00 CST 2016, time=2016-08-10, status=1, ipAttribution=)]
    2016-08-10 Guoxj3234

    继续学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=105150, encodeId=5a8a1051503c, content=谢谢!学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYa2dQhybFWiaOltUMXgzZLaoNhJDib46KINHiaFYjvYrawnjiaPdibLyGwJtjd0rId9ffwzEdNVtjngg/132, createdBy=e0a41314680, createdName=shaojinkang, createdTime=Fri Aug 26 22:40:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592336, encodeId=5a891592336ab, content=<a href='/topic/show?id=6dc2101853ed' target=_blank style='color:#2F92EE;'>#骨质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101853, encryptionId=6dc2101853ed, topicName=骨质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d018108513, createdName=Eleven17, createdTime=Fri Aug 12 03:20:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97567, encodeId=715b9e567de, content=好文章,值得阅读,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Aug 11 19:31:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97568, encodeId=4a889e56825, content=好文章,值得阅读,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEIsrUxHnicsiaqwzJibCks60HOicbEAgbNzUiciboMJDzsWg16OHTeNHhyYvTg6TDXTlOx7icnhttCYYe2ujYt0yND7dYusOsibl9XnQCE/0, createdBy=7ad21722200, createdName=jaysppr, createdTime=Thu Aug 11 19:31:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97313, encodeId=86ef9e313fe, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 10 16:56:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97290, encodeId=269e9e29052, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Wed Aug 10 15:56:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97265, encodeId=732f9e265d7, content=讲的非常广!, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLF3V7KY7WyRVHCticgpdCWVsqAsLGF1UrrVc5TFS9ZI2DrEs5plCGBUaLqHXvCU4fhImjFdZ9PjiaS/0, createdBy=8f971728670, createdName=1dee1b88m43(暂无匿称), createdTime=Wed Aug 10 13:47:00 CST 2016, time=2016-08-10, status=1, ipAttribution=)]
    2016-08-10 1dee1b88m43(暂无匿称)

    讲的非常广!

    0

相关资讯

男性朋友不可错过的骨质疏松症筛查

一项新的研究显示,与接受定期健康筛查的女性不同,男性很容易错过骨质疏松症筛查,即使没有错过,也会很难引起男性的重视。 因此,研究人员发现,男性很难接受骨骼治疗或采取相应的措施保障骨骼健康。 “女性群体会定期接受健康筛查,”Mary Ruppe 博士在医院的新闻发布会上表示,她是休斯顿卫理公会医院内分泌学家。“当女性到了相应的年龄后,她们就会接受初级保健医生和妇产科医师的骨密度筛查。但是对于男性

Bone:双膦酸盐类药物治疗骨质疏松症(荟萃分析)

目的:使用网络荟萃分析(NMA)评估双膦酸盐类药物(阿仑膦酸钠、利塞膦酸钠、伊班膦酸钠和唑来膦酸)治疗骨质疏松症的相对疗效。方法:根据PRISMA指南对文献进行系统回顾,使用NMA以确定双膦酸盐类药物对四个骨折结果(脊椎,非脊椎,髋部和手腕)的相对疗效,以及对股骨颈骨密度(BMD)百分比变化的影响。结果:研究共纳入了46项随机对照试验(RCT),27篇RCTs提供骨折数据,35篇RCTs提供了BM

Nat Med:中国学者揭密骨质疏松和骨肿瘤关键信号通路

4月12日,《自然—医学》在线发表了华东师大刘明耀、罗剑课题组和第二军医大学附属上海长征医院肖建如课题组关于骨质疏松和骨肿瘤治疗的最新发现,该成果的药物开发具有很高的应用价值。据介绍,患有骨质疏松症和骨肿瘤的人群日益增多,但临床上对这些疾病的认识和治疗还存在较大不足。在这项研究中,课题组联合攻关,在原有多项成果基础上展开深入研究,发现LGR4是破骨细胞中最重要细胞分化因子RANKL的新受体,进而深

Nat Commun:研究发现罕见骨质疏松症

来自苏黎世大学和苏黎世大学儿童医院的研究人员发现了第一个遗传性X染色体类型的先天性成骨发育不全症,也称为骨质疏松症。在瑞士约有300到400人,全球大约有五十万人患有骨质疏松症,该病会导致他们的骨头像玻璃一样脆弱。他们的骨形成不仅不好,而且身体组织中其它部位含有的结缔组织也受到了影响。Cecilia Giunta 和 Marianne Rohrbach说,研究人员发现了一种新型骨质疏松症,有两个家

Bone:绝经后女性使用抗抑郁药会增加骨质疏松症风险

骨质疏松症和抑郁症是全球主要的健康问题,那么治疗抑郁症的抗抑郁药和骨骼健康之间有什么关联呢?就此研究者进行了一项研究,探究绝经后妇女使用抗抑郁药物和随时间推移骨质流失间的关系。该研究从OSTPRE试验队列中共纳入了1988名57-67岁女性,分别在1999年和2004年检测参与者的股骨颈骨密度(BMD)。通过国家处方登记册获取参与者抗抑郁药物使用情况。使用多元回归分析在校正人体测量值、医学信息、身

Bone:特立帕肽治疗骨质疏松症+2型糖尿病患者

根据对DANCE试验的事后分析,成人2型糖尿病和骨质疏松症患者进行指定的Forteo治疗,可以降低椎骨骨折发生率,增加骨密度和减少背部疼痛。加利福尼亚大学的Ann V. Schwartz博士和同事分析了4042名骨折高风险的骨质疏松症成年人,其中291例患者有2型糖尿病(平均年龄为69岁)。分析包括了每天至少使用一个剂量的特立帕肽(20 µg/天,皮下注射);影像学诊断由调查人员自行裁决;使用DX